Michael Adams - AdvanSource Biomaterials CEO
| ASNBDelisted Stock | USD 0.55 0.00 0.00% |
CEO
Mr. Michael F. Adams is a President, Chief Executive Officer, Director of the Company. Mr. Adams was appointed as our President and Chief Executive Officer on August 7, 2006. From April 1, 2006 until August 7, 2006, Mr. Adams was our Vice President of Regulatory Affairs and Business Development. Prior to April 2006, Mr. Adams was the Vice President of PLC Systems, Inc. Prior to joining PLC Systems in September 2000, Mr. Adams was Vice President of Assurance Medical, Inc. Prior to joining Assurance Medical in June 1999, Mr. Adams was the Chief Operating Officer and Vice President of Regulatory Affairs and Quality Assurance of CardioTech from June 1998 to May 1999. From November 1994 through June 1998, Mr. Adams served as the Vice President of Cytyc Corporation since 2006.
| Age | 60 |
| Tenure | 18 years |
| Phone | 424 256 8560 |
| Web | http://www.advbiomaterials.com |
AdvanSource Biomaterials Management Efficiency
The company has return on total asset (ROA) of (495.4808) % which means that it has lost $495.4808 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (51.4634) %, meaning that it created substantial loss on money invested by shareholders. AdvanSource Biomaterials' management efficiency ratios could be used to measure how well AdvanSource Biomaterials manages its routine affairs as well as how well it operates its assets and liabilities. Previously, the company was engaged in the development of polymer materials for use in the design and development of medical devices used for treating a range of anatomical sites and disease states. EKIMAS Corporation was incorporated in 1993 and is based in Las Vegas, Nevada. Ekimas Corp is traded on OTC Exchange in the United States. AdvanSource Biomaterials [ASNB] is a Pink Sheet which is traded between brokers over the counter.Management Performance
| Return On Equity | -51.46 | |||
| Return On Asset | -495.48 |
AdvanSource Biomaterials Leadership Team
Elected by the shareholders, the AdvanSource Biomaterials' board of directors comprises two types of representatives: AdvanSource Biomaterials inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AdvanSource. The board's role is to monitor AdvanSource Biomaterials' management team and ensure that shareholders' interests are well served. AdvanSource Biomaterials' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AdvanSource Biomaterials' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Willaim ONeill, Independent Chairman of the Board | ||
| Bennett Yankowitz, CEO Pres | ||
| Michael Barretti, Independent Director | ||
| Mark Tauscher, Independent Director | ||
| Michael Adams, Chief Executive officer and President Treasurer, Secretary and Director | ||
| Ajay Nagle, Head Legal | ||
| Khristine Carroll, Senior Vice President - Commerical Operations |
AdvanSource Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is AdvanSource Biomaterials a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Pair Trading with AdvanSource Biomaterials
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AdvanSource Biomaterials position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AdvanSource Biomaterials will appreciate offsetting losses from the drop in the long position's value.Moving together with AdvanSource Pink Sheet
| 0.62 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
Moving against AdvanSource Pink Sheet
| 0.88 | GE | GE Aerospace Financial Report 23rd of July 2024 | PairCorr |
| 0.87 | XOM | Exxon Mobil Corp Earnings Call Tomorrow | PairCorr |
| 0.8 | CAT | Caterpillar Earnings Call Today | PairCorr |
| 0.77 | MMM | 3M Company Earnings Call This Week | PairCorr |
| 0.75 | DD | Dupont De Nemours Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to AdvanSource Biomaterials could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AdvanSource Biomaterials when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AdvanSource Biomaterials - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AdvanSource Biomaterials to buy it.
The correlation of AdvanSource Biomaterials is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AdvanSource Biomaterials moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AdvanSource Biomaterials moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AdvanSource Biomaterials can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in AdvanSource Pink Sheet
If you are still planning to invest in AdvanSource Biomaterials check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AdvanSource Biomaterials' history and understand the potential risks before investing.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |